Assay Detail
Binding
CHEMBL3887654
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Z′-LYTE Screening Assay: Axitinib was tested using a Z′-LYTE Screening Protocol (Invitrogen, Carlsbad, Calif.). Axitinib was prepared in 100% DMSO, and added to the reaction for a final DMSO concentration of 1%. Inhibitor concentrations varied from 1.0 μM to 0.00003 μM. Typical reactions were 10 μL, contained ABL1 or ABL1 [T315I], ATP (ABL1; 10 μM and ABL1 [T315I]; 5 μM), 2.0 μM Tyr 02 peptide, 10 mM MgCl2, 1.0 mM EGTA, 0.01% BRIJ-35, 1% DMSO in 50 mM HEPES pH 7.5. The mixture was incubated in a 384-well polypropylene plate at room temperature for an hour and terminated by the addition of 5 μL of a 1:64 dilution of the development reagent utilized with Z′-LYTE® Screening Protocol, followed by a 30 second shake.
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Confidence | 8 — Homologous single protein target |
| Curated By | Autocuration |
Publication
N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 1 | 9.38 | 9.38 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL1289926 | AXITINIB | 4.0 | 1 | 9.38 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL1289926 | AXITINIB | IC50 | = | 0.418 | nM | 9.38 |